{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05836324",
            "orgStudyIdInfo": {
                "id": "INCA 33890-101"
            },
            "organization": {
                "fullName": "Incyte Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors",
            "officialTitle": "A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-to-evaluate-the-safety-of-in-participants-with-advanced-or-metastatic-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-24",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-12-24",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12-24",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-14",
            "studyFirstSubmitQcDate": "2023-04-26",
            "studyFirstPostDateStruct": {
                "date": "2023-05-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Incyte Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To evaluate the safety, tolerability, and DLTs and determine the MTD and/or RDE(s) of INCA33890 in participants with select advanced or metastatic solid tumors."
        },
        "conditionsModule": {
            "conditions": [
                "Solid Tumors",
                "Advanced Solid Tumors",
                "Metastatic Solid Tumors"
            ],
            "keywords": [
                "Solid Tumors",
                "INCA33890"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 165,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Part 1a - Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "INCA33890 will be administered at a protocol defined starting regimen intravenously. Subsequent dose regimens will be determined during study conduct.",
                    "interventionNames": [
                        "Drug: INCA33890"
                    ]
                },
                {
                    "label": "Part 1b-Dose Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "INCA33890 will be administered at the recommended dose(s) for expansion (RDE\\[s\\]) in participants with advanced or metastatic ICI sensitive or ICI non sensitive tumor types",
                    "interventionNames": [
                        "Drug: INCA33890"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "INCA33890",
                    "description": "INCA33890 will be administered at protocol defined dose.",
                    "armGroupLabels": [
                        "Part 1a - Dose Escalation",
                        "Part 1b-Dose Expansion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with Dose Limiting Toxicities (DLTs)",
                    "timeFrame": "Up to 28 days"
                },
                {
                    "measure": "Number of participants with Treatment Emerging Adverse Events (TEAEs)",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Number of participants with TEAEs leading to dose modification or discontinuation",
                    "timeFrame": "Up to 2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Objective response Rate",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Disease Control Rate",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Duration of Response",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Pharmacokinetics Parameter : Cmax of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : Tmax of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : Cmin of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : AUC(0-t) of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : AUC 0-\u221e of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : CL/F of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : Vz/F of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                },
                {
                    "measure": "Pharmacokinetics Parameter : t1/2 of INCA33890",
                    "timeFrame": "Pre dose - Day 1 of Cycle 1(C1D1)- 28 (each cycle is 28 days), Day 15 of Cycle 1-3; 10min and 4hrs Post dose(PD) - C1D1,C1D4, 24hrs PD C1D2, any time PD Day 4, 8, 22, of Cycle 1, and any time during 30 day Follow Up"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* \u226518 years old\n* Histologically or cytologically confirmed advanced or metastatic malignancies\n* Participants must have experienced disease progression after treatment with available therapies, including anti-PD-(L)1 or anti-CTLA4 therapy if applicable, that are known to confer clinical benefit, or who are intolerant to, or ineligible for standard treatment. Prior anti-PD-(L)1 therapy should not have been discontinued because of intolerance.\n* ECOG performance status score of 0 or 1.\n* Willingness to undergo pre- and on-treatment tumor biopsy (core or excisional). Biopsies are mandatory for Part 1b cohorts only.\n* Presence of measurable disease according to RECIST v1.1\n\nExclusion Criteria:\n\n* Any known additional malignancy that is progressing or requires active treatment, or history of other malignancy within 2 years\n* Not recovered to \u2264 Grade 1 or baseline from residual toxicities of prior therapy\n* Has active autoimmune disease requiring systemic immunosuppression with corticosteroids Brain or CNS metastases untreated or that have progressed\n* History of organ transplant, including allogeneic stem cell transplantation.\n* Received more than 4 prior anticancer regimen(s) for advanced or metastatic disease.\n* History of clinically significant or uncontrolled cardiac disease\n* Active HBV (or at risk of activation), active HCV, or HIV positive\n* Is on chronic systemic steroids (\\> 10 mg/day of prednisone or equivalent).\n* Chronic or current active infectious disease requiring systemic antibiotics, antifungal, or antiviral treatment\n* Participants that have been initiated on or had modifications in anticoagulation therapies within the last 3 months prior to first dose of treatment.\n* Significant concurrent, uncontrolled medical condition, eg:\n\n  * Cardiovascular: Participants with known vasculitis, aneurisms, and other vascular malformations of clinical significance\n* Participants with adequate laboratory values within the protocol defined ranges.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Incyte Corporation Call Center (US)",
                    "role": "CONTACT",
                    "phone": "1.855.463.3463",
                    "email": "medinfo@incyte.com"
                },
                {
                    "name": "Incyte Corporation Call Center (ex-US)",
                    "role": "CONTACT",
                    "phone": "+800 00027423",
                    "email": "eumedinfo@incyte.com"
                }
            ],
            "locations": [
                {
                    "facility": "The Angeles Clinic and Research Institute",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90025",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Cancer and Hematology Centers of Western Michigan-Start Midwest",
                    "status": "RECRUITING",
                    "city": "Grand Rapids",
                    "state": "Michigan",
                    "zip": "49546",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.96336,
                        "lon": -85.66809
                    }
                },
                {
                    "facility": "Hackensack University Medical Center",
                    "status": "RECRUITING",
                    "city": "Hackensack",
                    "state": "New Jersey",
                    "zip": "07601",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.88593,
                        "lon": -74.04347
                    }
                },
                {
                    "facility": "Lifespan Cancer Research Institute",
                    "status": "RECRUITING",
                    "city": "Providence",
                    "state": "Rhode Island",
                    "zip": "02903",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.82399,
                        "lon": -71.41283
                    }
                },
                {
                    "facility": "University of Texas Md Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "South Texas Accelerated Research Therapeutics",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Rigshospitalet Uni of Hospital of Copenhagen",
                    "status": "RECRUITING",
                    "city": "Copenhagen",
                    "zip": "02100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.67594,
                        "lon": 12.56553
                    }
                },
                {
                    "facility": "Herlev Og Gentofte Hospital",
                    "status": "RECRUITING",
                    "city": "Herlev",
                    "zip": "02730",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.72366,
                        "lon": 12.43998
                    }
                },
                {
                    "facility": "Odense University Hospital",
                    "status": "RECRUITING",
                    "city": "Odense C",
                    "zip": "05000",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.39594,
                        "lon": 10.38831
                    }
                },
                {
                    "facility": "Vejle Hospital",
                    "status": "RECRUITING",
                    "city": "Vejle",
                    "zip": "07100",
                    "country": "Denmark",
                    "geoPoint": {
                        "lat": 55.70927,
                        "lon": 9.5357
                    }
                },
                {
                    "facility": "Centre Leon Berard",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "zip": "69373",
                    "country": "France",
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Institut Paoli Calmettes",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Marseille",
                    "zip": "13009",
                    "country": "France",
                    "geoPoint": {
                        "lat": 43.29551,
                        "lon": 5.38958
                    }
                },
                {
                    "facility": "Institut Gustave Roussy",
                    "status": "RECRUITING",
                    "city": "Villejuif Cedex",
                    "zip": "94805",
                    "country": "France",
                    "geoPoint": {
                        "lat": 48.7939,
                        "lon": 2.35992
                    }
                },
                {
                    "facility": "Fondazione Irccs Istituto Nazionale Del Tumori Di Milano",
                    "status": "RECRUITING",
                    "city": "Milano",
                    "zip": "20133",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.46427,
                        "lon": 9.18951
                    }
                },
                {
                    "facility": "Irccs Istituto Clinico Humanitas",
                    "status": "RECRUITING",
                    "city": "Rozzano",
                    "zip": "20089",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.38193,
                        "lon": 9.1559
                    }
                },
                {
                    "facility": "Centro Ricerche Cliniche Di Verona (Crc)",
                    "status": "RECRUITING",
                    "city": "Verona",
                    "zip": "37134",
                    "country": "Italy",
                    "geoPoint": {
                        "lat": 45.4299,
                        "lon": 10.98444
                    }
                },
                {
                    "facility": "Start Barcelona",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08023",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital General Universitario Vall D Hebron",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Fundacion Jimenez Diaz University Hospital",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28040",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitario 12 de Octubre",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28041",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Centro Integral Oncologico Clara Campal",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "zip": "28050",
                    "country": "Spain",
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Istituto Oncologico Della Svizzera Italiana",
                    "status": "RECRUITING",
                    "city": "Bellinzona",
                    "zip": "06500",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 46.19278,
                        "lon": 9.01703
                    }
                },
                {
                    "facility": "Centre Hospitalier Universitaire Vaudois (Chuv)",
                    "status": "RECRUITING",
                    "city": "Lausanne",
                    "zip": "01011",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 46.516,
                        "lon": 6.63282
                    }
                },
                {
                    "facility": "Kantonsspital St. Gallen",
                    "status": "RECRUITING",
                    "city": "St. Gallen",
                    "zip": "09007",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 47.42391,
                        "lon": 9.37477
                    }
                },
                {
                    "facility": "Cambridge University Hospitals Nhs Foundation Trust",
                    "status": "RECRUITING",
                    "city": "Cambridge",
                    "zip": "CB2 0QQ",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 52.2,
                        "lon": 0.11667
                    }
                },
                {
                    "facility": "Guys and St Thomas Nhs Foundation Trust",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "SE1 9RT",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "Imperial College Healthcare Nhs Trust - Hammersmith Hospital",
                    "status": "RECRUITING",
                    "city": "London",
                    "zip": "W12 0HS",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 51.50853,
                        "lon": -0.12574
                    }
                },
                {
                    "facility": "The Christie Nhs Foundation Trust Uk",
                    "status": "RECRUITING",
                    "city": "Manchester",
                    "zip": "M20 4BV",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 53.48095,
                        "lon": -2.23743
                    }
                },
                {
                    "facility": "Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust",
                    "status": "RECRUITING",
                    "city": "Newcastle Upon Tyne",
                    "zip": "NE7 7DN",
                    "country": "United Kingdom",
                    "geoPoint": {
                        "lat": 54.97328,
                        "lon": -1.61396
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "Incyte shares data with qualified external researchers after a research proposal is submitted. These requests are reviewed and approved by a review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.\n\nThe trial data availability is according to the criteria and process described on https://www.incyte.com/our-company/compliance-and-transparency",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP"
            ],
            "timeFrame": "Data will be shared after the primary publication or 2 years after the study has ended for market authorized products and indications.",
            "accessCriteria": "Data from eligible studies will be shared with qualified researchers according to the criteria and process described in the Data Sharing section of the www.incyteclinicaltrials.com website. For approved requests, the researchers will be granted access to anonymized data under the terms of a data sharing agreement.",
            "url": "https://www.incyte.com/our-company/compliance-and-transparency"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ]
        }
    },
    "hasResults": false
}